FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034192724> ?p ?o ?g. }

• W2034192724 endingPage "2153" @default.
• W2034192724 startingPage "2145" @default.
• W2034192724 abstract "Adenovirus (Ad)-based gene therapy represents a potentially viable strategy for treating colorectal cancer. The infectivity of serotype 5 adenovirus (Ad.5), routinely used as a transgene delivery vector, is dependent on Coxsackie-adenovirus receptors (CAR). CAR expression is downregulated in many cancers thus preventing optimum therapeutic efficiency of Ad.5-based therapies. To overcome the low CAR problem, a serotype chimerism approach was used to generate a recombinant Ad (Ad.5/3) that is capable of infecting cancer cells via Ad.3 receptors in a CAR-independent manner. We evaluated the improved transgene delivery and efficacy of Ad.5/3 recombinant virus expressing melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), an effective wide-spectrum cancer-selective therapeutic. In low CAR human colorectal cancer cells RKO, wild-type Ad.5 virus expressing mda-7/IL-24 (Ad.5-mda-7) failed to infect efficiently resulting in lack of expression of MDA-7/IL-24 or induction of apoptosis. However, a recombinant Ad.5/3 virus expressing mda-7/IL-24 (Ad.5/3-mda-7) efficiently infected RKO cells resulting in higher MDA-7/IL-24 expression and inhibition of cell growth both in vitro and in nude mice xenograft models. Addition of the novel Bcl-2 family pharmacological inhibitor Apogossypol derivative BI-97C1 (Sabutoclax) significantly augmented the efficacy of Ad.5/3-mda-7. A combination regimen of suboptimal doses of Ad.5/3-mda-7 and BI-97C1 profoundly enhanced cytotoxicity in RKO cells both in vitro and in vivo. Considering the fact that Ad.5-mda-7 has demonstrated significant objective responses in a Phase I clinical trial for advanced solid tumors, Ad.5/3-mda-7 alone or in combination with BI-97C1 would be predicted to exert significantly improved therapeutic efficacy in colorectal cancer patients. J. Cell. Physiol. 227: 2145–2153, 2012. © 2011 Wiley Periodicals, Inc." @default.
• W2034192724 created "2016-06-24" @default.
• W2034192724 creator A5022987623 @default.
• W2034192724 creator A5024866939 @default.
• W2034192724 creator A5031490587 @default.
• W2034192724 creator A5033665986 @default.
• W2034192724 creator A5036159485 @default.
• W2034192724 creator A5037565884 @default.
• W2034192724 creator A5039004886 @default.
• W2034192724 creator A5043450835 @default.
• W2034192724 creator A5059438505 @default.
• W2034192724 creator A5061036144 @default.
• W2034192724 creator A5069980003 @default.
• W2034192724 creator A5073677610 @default.
• W2034192724 creator A5076447196 @default.
• W2034192724 creator A5076702481 @default.
• W2034192724 creator A5082755854 @default.
• W2034192724 creator A5090380865 @default.
• W2034192724 creator A5091194969 @default.
• W2034192724 date "2012-01-23" @default.
• W2034192724 modified "2023-10-15" @default.
• W2034192724 title "Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells" @default.
• W2034192724 cites W1971597312 @default.
• W2034192724 cites W1976253176 @default.
• W2034192724 cites W1978328945 @default.
• W2034192724 cites W1981397338 @default.
• W2034192724 cites W1988177186 @default.
• W2034192724 cites W1989513172 @default.
• W2034192724 cites W1992741971 @default.
• W2034192724 cites W1996528377 @default.
• W2034192724 cites W2001401716 @default.
• W2034192724 cites W2004109703 @default.
• W2034192724 cites W2005768073 @default.
• W2034192724 cites W2006366803 @default.
• W2034192724 cites W2008078589 @default.
• W2034192724 cites W2014944687 @default.
• W2034192724 cites W2019072035 @default.
• W2034192724 cites W2022315435 @default.
• W2034192724 cites W2022494582 @default.
• W2034192724 cites W2026711972 @default.
• W2034192724 cites W2031900842 @default.
• W2034192724 cites W2043026554 @default.
• W2034192724 cites W2043654385 @default.
• W2034192724 cites W2073254087 @default.
• W2034192724 cites W2074810910 @default.
• W2034192724 cites W2075776905 @default.
• W2034192724 cites W2078455874 @default.
• W2034192724 cites W2078549990 @default.
• W2034192724 cites W2080543048 @default.
• W2034192724 cites W2081941885 @default.
• W2034192724 cites W2091334792 @default.
• W2034192724 cites W2092016735 @default.
• W2034192724 cites W2096371251 @default.
• W2034192724 cites W2124375652 @default.
• W2034192724 cites W2141019354 @default.
• W2034192724 cites W2143064142 @default.
• W2034192724 cites W2146400618 @default.
• W2034192724 cites W2146415292 @default.
• W2034192724 cites W2151790613 @default.
• W2034192724 cites W2153389806 @default.
• W2034192724 cites W2156383817 @default.
• W2034192724 cites W2162814912 @default.
• W2034192724 cites W2166105600 @default.
• W2034192724 cites W2170815810 @default.
• W2034192724 cites W2234798757 @default.
• W2034192724 cites W2323327334 @default.
• W2034192724 doi "https://doi.org/10.1002/jcp.22947" @default.
• W2034192724 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3228880" @default.
• W2034192724 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21780116" @default.
• W2034192724 hasPublicationYear "2012" @default.
• W2034192724 type Work @default.
• W2034192724 sameAs 2034192724 @default.
• W2034192724 citedByCount "43" @default.
• W2034192724 countsByYear W20341927242012 @default.
• W2034192724 countsByYear W20341927242013 @default.
• W2034192724 countsByYear W20341927242014 @default.
• W2034192724 countsByYear W20341927242015 @default.
• W2034192724 countsByYear W20341927242016 @default.
• W2034192724 countsByYear W20341927242017 @default.
• W2034192724 countsByYear W20341927242018 @default.
• W2034192724 countsByYear W20341927242019 @default.
• W2034192724 countsByYear W20341927242021 @default.
• W2034192724 countsByYear W20341927242023 @default.
• W2034192724 crossrefType "journal-article" @default.
• W2034192724 hasAuthorship W2034192724A5022987623 @default.
• W2034192724 hasAuthorship W2034192724A5024866939 @default.
• W2034192724 hasAuthorship W2034192724A5031490587 @default.
• W2034192724 hasAuthorship W2034192724A5033665986 @default.
• W2034192724 hasAuthorship W2034192724A5036159485 @default.
• W2034192724 hasAuthorship W2034192724A5037565884 @default.
• W2034192724 hasAuthorship W2034192724A5039004886 @default.
• W2034192724 hasAuthorship W2034192724A5043450835 @default.
• W2034192724 hasAuthorship W2034192724A5059438505 @default.
• W2034192724 hasAuthorship W2034192724A5061036144 @default.
• W2034192724 hasAuthorship W2034192724A5069980003 @default.
• W2034192724 hasAuthorship W2034192724A5073677610 @default.
• W2034192724 hasAuthorship W2034192724A5076447196 @default.
• W2034192724 hasAuthorship W2034192724A5076702481 @default.

• next